What is the Future Scope of Plasma Therapy Market amidst COVID-19?

Posted on
by

What is the Future Scope of Plasma Therapy Market amidst COVID-19?
Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User (Hospitals & Clinics, Research Institutions) by Region (North America, Europe, Asia-Pacific, Latin America, And Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2020-2026

The Global Plasma Therapy Market is estimated to grow at a CAGR of 15.2% during the forecast period 2020-2026. As per the analysis, the global market is witnessing positive growth trends owing to increasing geriatric population, increasing number of orthopaedic disorders and growth in demand for minimally invasive therapies.

Plasma therapy is a conventional technique that is widely used in dermatologic, dentistry and orthopaedic specialties. Plasma therapy have its extensive application in androgenetic alopecia, face rejuvenation and wound healing.

GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC91

In the current scenario, the global plasma therapy market is witnessing a sudden spike due to wide spread of COVID-19 disease worldwide. On April 8, 2020, the U.S. Food and Drug Administration (FDA) has issued guidance to offer recommendations to investigators and healthcare providers on the study and administration of investigational convalescent plasma that can be collected from COVID-19 recovered patients during the public health emergency. Moreover, on 13th April 2020, the New Jersey based hospital named Valley Health System have given the first dose of convalescent plasma therapy to a COVID-19 patient. As per some studies, Plasma therapy in the US and China worked when used with other interventions like accurate oxygen support, as the therapy has been used in previous pandemics such as in the SARS outbreak, H1N1, Middle Eastern Respiratory Syndrome (MERS) and the 1918 Spanish flu. There is currently no treatment for COVID-19 and the vaccines under test seem at least a year away. However, the plasma treatment seems to be a viable option of treatment in the absence of a vaccine.

You can request an in-depth analysis detailing the impact of COVID-19 on the Plasma Therapy Market: https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC91

Segmentation Overview of the Global Plasma Therapy Market

The Global Plasma Therapy Market is segmented on the basis of Type, Source, Application, and End-User. The market was studied in-depth considering various market segments and its sub-segments to analyse the market in detail.

The Type Segment of the Global Plasma Therapy Market is Sub-Segmented into:

  • Pure PRP
  • Leukocyte-Rich PRP
  • Pure Platelet-Rich Fibrin
  • Leukocyte-Rich Fibrin

The Source Segment of the Global Plasma Therapy Market is Sub-Segmented into:

  • Autologous
  • Allogenic

The Application Segment of the Global Plasma Therapy Market is Sub-Segmented into:

  • Orthopaedic
  • Dermatology
  • Cardiac Muscle Injury
  • Dental
  • Nerve Injury
  • Others

The End-Users Segment of the Global Plasma Therapy Market is Sub-Segmented into:

  • Hospitals and Clinics
  • Research Institutes

Geographical Overview of the Global Plasma Therapy Market

The geographical segmentation of the global market is categorized into various regions namely North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. As per the analysis, the North America market is expected to dominate the global market, owing to high number of COVID-19 patients in the U.S.; as of 13th April 2020, the country reported more than 5,50,000 COVID-19 cases which is followed by Spain and Italy. Considering the future period, the North American Market will still dominate the global market due to technologically advanced healthcare system of the region and high budget allocation by the regional government to the healthcare system.

Key Players Insights

Octapharma, China Biologic Products Holdings, Inc., Bio Products Laboratory Ltd., Grifols, S.A., Kedrion S.p.A, CSL Limited, Cambryn Biologics, The LFB Group, Biolife Plasma Services and Terumo BCT, Inc. are some major players included in the research study of the global plasma therapy market.

Target Audience for this Report:

  • Platelet-rich Plasma (PRP) Manufacturers and Suppliers
  • Academic Medical Centres & Universities
  • Medical Research Laboratories
  • Business Research & Consulting Service Providers
  • Research & Development (R&D) Companies
  • Hospitals & Clinics
  • Academic Research Institutes

Reasons to Purchase the Research Report

  • The research study offers in-depth demand-supply gap analysis.
  • The research report provides price trends of the global plasma therapy market.
  • The study explains about the production capacity of major market players along with potentials of new market entrants.
  • The study also studies the impact of COVID-19 on the plasma therapy market.

Rquest Sample Pages @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC91

Media Contact
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Phone: +91-9997112116
Address:Classic Tower, Rajnagar Extension
City: Ghaziabad
State: UP, 201017
Country: India
Website: www.reportocean.com